Format

Send to:

Choose Destination
See comment in PubMed Commons below
Ther Adv Cardiovasc Dis. 2008 Oct;2(5):387-405. doi: 10.1177/1753944708093411. Epub 2008 Aug 21.

Recurrent stroke: where do we stand with the secondary prevention of noncardioembolic ischaemic strokes?

Author information

  • 1Institute of Neurology, Sobell Department of Motor Neuroscience and Movement Disorders, University College London (UCL), London, UK. p.talelli@ion.ucl.ac.uk

Abstract

Strokes recur in 6-20% of the patients, most commonly within the first year; after a TIA or minor stroke; most recurrences will occur within the first 90 days. Our ability to identify patients at high risk is poor and most recurrent strokes cannot be explained by traditional risk factors. In 30-45% of the cases the second stroke will be of a different subtype. Moreover, patients are faced with other risks, like cardiac events and cognitive decline. With the population aging, the need for timely and effective secondary prevention strategies is more pressing than ever. This paper summarizes recent advances in pharmacological secondary prevention after a non-cardioembolic ischaemic stroke, and highlights critical questions still in need of answers.

PMID:
19124436
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk